Login to Your Account

Invitrogen Buying Technology From Vertex Unit For $95M Cash

By Kim Coghill

Wednesday, February 5, 2003
Invitrogen Corp. agreed to pay $95 million in cash to purchase certain product lines and technology rights from PanVera LLC, a wholly owned subsidiary of Vertex Pharmaceuticals Inc. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription